ENT Department, Santa Chiara Hospital, Trento, Italy.
Unit of Otorhinolaryngology, Head & Neck Department Policlinico G.B. Rossi, University of Verona, Verona, Italy.
Pathologica. 2024 Jun;116(3):144-152. doi: 10.32074/1591-951X-980.
Melanoma of the external auditory canal (EAC) is particularly rare and poorly understood, with limited available data on management and survival. This systematic review aims to analyze existing data and provide insights into the management and prognosis the beginning of EAC melanoma. It is conducted using Pubmed and Scopus databases from the beginning to July 2023 and it follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 guidelines. Searches are performed using the search string "(melanoma) AND (external auditory canal)". The review includes a total of 30 patients diagnosed with EAC melanoma, supplemented by an additional case from the authors' clinical experience. The role of Breslow thickness as a determining factor for the choice of surgery remains inconclusive due to limited available data. Sentinel lymph node biopsy and adjuvant therapy are sparingly employed, indicating the need for standardized guidelines. Patients in the study demonstrate a 50% overall survival rate at 5 years. EAC Melanoma is a rare and aggressive malignancy with limited therapeutic guidelines. Surgical interventions, including wide local excision and lateral temporal bone resection, are the primary treatment options for patients without distant metastases.
外耳道黑色素瘤(EAC)极为罕见且了解甚少,其管理和生存的相关数据有限。本系统评价旨在分析现有数据,为 EAC 黑色素瘤的管理和预后提供见解。该研究使用 Pubmed 和 Scopus 数据库,从 2023 年 7 月开始进行,遵循系统评价和荟萃分析的首选报告项目(PRISMA)2020 指南。搜索使用的搜索字符串为“(melanoma) AND (external auditory canal)”。该评价共纳入 30 例诊断为 EAC 黑色素瘤的患者,并通过作者的临床经验补充了另外 1 例病例。由于现有数据有限,Breslow 厚度作为手术选择的决定因素的作用仍不确定。前哨淋巴结活检和辅助治疗的应用较少,表明需要制定标准化指南。研究中的患者 5 年总生存率为 50%。EAC 黑色素瘤是一种罕见且侵袭性的恶性肿瘤,治疗指南有限。对于没有远处转移的患者,手术干预,包括广泛局部切除和外侧颞骨切除术,是主要的治疗选择。